Therefore, we propose a positive feedback loop in which IL-4 favors its own production via NLRP3 in CD4+ T cells, thereby further enriching a Th2 environment in CTCL lesions. The gene discussed is IL4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.